Site-specific drug-releasing polypeptide nanocarriers with enhanced therapeutic efficacy against dru

来源 :Fourth Symposium on Innovative Polymers for Controlled Deliv | 被引量 : 0次 | 上传用户:forisa1
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Repeated administration of chemotherapeutic agents leads to drug resistance of the tumors,which significantly hinders drug accumulation in tumors and finally results in failure in chemotherapy.Therefore,how to increase the effective concentration of chemotherapeutic agents in drug-resistant tumors will be a great challenge.
其他文献
A facile self-assembly method of forming paclitaxel/chitosan (PTX/CS) core-shell nanofibers (NFs) for drug-eluting stent (DES) application is developed.The NFs are tens to hundreds nanometers in diame
Lysosomal disruption and escape ability is critically important to protect entrapment of drugs and acquire maximum therapeutic efficacy in the case of cellular uptake through lysosomal endocytosis[1].
Protein therapeutics offers a most effective treatment for many human diseases including diabetes,cardiovascular diseases,and malignant tumors[1,2].Unlike chemotherapeutics that cause notorious side e
Antibiotics have been considered as the most efficient antibacterial agent and saved millions of patients in the past decades.Among them,aminoglycosides are listed as critically important antimicrobia
A short Nur77-derived peptide NuBCP-9 was reported to exhibit the remarkable apoptotic capability to Bcl-2-positive cancer cells in our previous work[1].However,it was not accessible to cell interior
Targeted delivery of chemotherapeutic agents to desired lesion sites was a great challenge in clinical cancer treatment especially for highly metastatic malignancies.However,the individual targeting s
Biodegradable nanoparticles based on poly(D,L-lactide-co-glycolide) (PLGA,a FDA-approved polymer) have attracted an enormous interest for controlled drug delivery[1].However,their clinical application
As one of the main therapeutic methods toward cancers,chemotherapy can inhibit tumor growth to a certain extent[1].However,it is usually restricted with the severe cytotoxicity of anti-tumor drugs aga
Chemotherapy is the standard treatment for various types of cancers.However,the conventional maximum tolerated doses of chemotherapy exhibits severe side effects such as acute and cumulative toxicity,
Utilization of ionic liquids (ILs) as drug carriers offers many advantages in topical dermal drug delivery to overcome potential problems with solid state active pharmaceutical ingredients,such as pol